Oncology nurses and APPs should prioritize active listening and deeper patient engagement to build trusting, long-term relationships with patients with MPNs.
Phase 1 data indicate invikafusp alfa's potential as a precision cancer immunotherapeutic in solid tumors that have ...
Panelists discuss how to help patients weigh the risks and benefits of different treatment options for paroxysmal nocturnal hemoglobinuria (PNH), outlining tools and techniques used to ensure that ...
Liso-Cel Shows Comparable Real-World Outcomes in Relapsed/Refractory LBCL ...
Liso-Cel Shows Comparable Real-World Outcomes in Relapsed/Refractory LBCL ...
Liso-Cel Shows Comparable Real-World Outcomes in Relapsed/Refractory LBCL ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
An oncology nurse practitioner's transition from private practice to cancer research offers insights for nurses exploring new career paths within oncology.
First-line treatment with the immunotherapy combination nivolumab (Opdivo) plus ipilimumab (Yervoy) improved progression-free survival (PFS) compared to chemotherapy in patients with microsatellite ...
Panelists discuss how oral and subcutaneous therapies have improved the quality of life for patients with EGFR-mutated ...
Analysis of two trials indicates psilocybin-assisted psychotherapy may benefit the mental health of patients with cancer.
The SU2C-SARC032 study demonstrated that pembrolizumab combined with radiotherapy and surgery was well tolerated, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback